Levent Selamoğlu is a graduate of Eskişehir Maarif College and Boğaziçi University Faculty of Administrative Sciences. He completed his master’s degree at Istanbul University Institute of Business Economics. Selamoğlu has held positions at Enka, The Coca-Cola Export Corp., Ericsson Telecommunications Inc., GlaxoSmithKline Pharmaceuticals Inc., and Mustafa Nevzat Pharmaceuticals Inc.
Currently, he serves as the Chairman of the Board at Frontier Pharma in the UK, Chairman of the Board at Zdravlje Leskovac in Serbia, Chairman of the Board at Afrigen Biologics in South Africa, Board Member at Avacare Global Healthcare in South Africa, and Vice President of the Board of the Turkish Pharmaceutical Manufacturers Association. Since April 2015, he has also been a board member at Saya Holding, Folkart Yapı, and Humanis Pharmaceuticals.
